lissamine rhodamine b sulfonyl chloride has been researched along with Parkinson Disease in 1 studies
*Parkinson Disease: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75) [MeSH]
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, G; He, Y; Liu, S; Liu, Z; Sun, J; Suo, Y; Wei, N; You, J; Zhao, XE; Zhou, Y; Zhu, S | 1 |
1 other study(ies) available for lissamine rhodamine b sulfonyl chloride and Parkinson Disease
Article | Year |
---|---|
In situ derivatization-ultrasound-assisted dispersive liquid-liquid microextraction for the determination of neurotransmitters in Parkinson's rat brain microdialysates by ultra high performance liquid chromatography-tandem mass spectrometry.
Topics: Acetonitriles; Animals; Brain Chemistry; Bromobenzenes; Buffers; Catecholamines; Chromatography, High Pressure Liquid; Green Chemistry Technology; Limit of Detection; Liquid Phase Microextraction; Microdialysis; Neurotransmitter Agents; Parkinson Disease; Rats; Rhodamines; Tandem Mass Spectrometry; Time Factors; Ultrasonics | 2016 |